RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
EZZ Life Science Holdings Stock

EZZ Life Science Holdings Equity 2024

EZZ Life Science Holdings Equity

21.32 M AUD

Ticker

EZZ.AX

ISIN

AU0000130569

In 2024, EZZ Life Science Holdings's equity was 21.32 M AUD, a 87.25% increase from the 11.39 M AUD equity in the previous year.

EZZ Life Science Holdings Aktienanalyse

What does EZZ Life Science Holdings do?

EZZ Life Science Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing EZZ Life Science Holdings's Equity

EZZ Life Science Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding EZZ Life Science Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating EZZ Life Science Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

EZZ Life Science Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in EZZ Life Science Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about EZZ Life Science Holdings stock

What is the equity of EZZ Life Science Holdings this year?

EZZ Life Science Holdings has equity of 21.32 M AUD this year.

What was the equity of EZZ Life Science Holdings compared to the previous year?

The equity of EZZ Life Science Holdings has increased/decreased by 87.25% increased compared to the previous year.

What impact does a high equity have on investors of EZZ Life Science Holdings?

A high equity is advantageous for investors of EZZ Life Science Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of EZZ Life Science Holdings?

A low equity can be a risk for investors of EZZ Life Science Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of EZZ Life Science Holdings affect the company?

An increase in equity of EZZ Life Science Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of EZZ Life Science Holdings affect the company?

A reduction in equity of EZZ Life Science Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of EZZ Life Science Holdings?

Some factors that can affect the equity of EZZ Life Science Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of EZZ Life Science Holdings so important for investors?

The equity of EZZ Life Science Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can EZZ Life Science Holdings take to change the equity?

To change equity, EZZ Life Science Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does EZZ Life Science Holdings pay?

Over the past 12 months, EZZ Life Science Holdings paid a dividend of 0.02 AUD . This corresponds to a dividend yield of about 0.54 %. For the coming 12 months, EZZ Life Science Holdings is expected to pay a dividend of 0.02 AUD.

What is the dividend yield of EZZ Life Science Holdings?

The current dividend yield of EZZ Life Science Holdings is 0.54 %.

When does EZZ Life Science Holdings pay dividends?

EZZ Life Science Holdings pays a quarterly dividend. This is distributed in the months of December, June, November, June.

How secure is the dividend of EZZ Life Science Holdings?

EZZ Life Science Holdings paid dividends every year for the past 7 years.

What is the dividend of EZZ Life Science Holdings?

For the upcoming 12 months, dividends amounting to 0.02 AUD are expected. This corresponds to a dividend yield of 0.6 %.

In which sector is EZZ Life Science Holdings located?

EZZ Life Science Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EZZ Life Science Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EZZ Life Science Holdings from 6/17/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did EZZ Life Science Holdings pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of EZZ Life Science Holdings in the year 2023?

In the year 2023, EZZ Life Science Holdings distributed 0.027 AUD as dividends.

In which currency does EZZ Life Science Holdings pay out the dividend?

The dividends of EZZ Life Science Holdings are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EZZ Life Science Holdings

Our stock analysis for EZZ Life Science Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EZZ Life Science Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.